• Je něco špatně v tomto záznamu ?

Early identification of women with HELLP syndrome who need plasma exchange after delivery

O. Simetka, J. Klat, J. Gumulec, E. Dolezalkova, D. Salounova, M. Kacerovsky,

. 2015 ; 52 (1) : 54-9. [pub] 20141218

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu klinické zkoušky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031523

OBJECTIVES: To compare the laboratory course of HELLP syndrome between patients who recover and those who progress to postpartum thrombotic microangiopathic syndrome (PTMS) and require postpartum plasma exchange (PPEX) and to describe maternal characteristics and morbidity in women with PTMS. METHODS: In this retrospective analysis, 81 patients recovered and 5 progressed. Values for aspartate aminotransferase (AST), lactate dehydrogenase (LDH), bilirubin, platelets (Plt), urea, and creatinine at 0, 8, 16, 24, 48, and 72 hours postpartum in both groups were analyzed and compared. We also described maternal characteristics and morbidity of patients who progressed to PTMS. RESULTS: Patient groups differed significantly at 72 hours postpartum for Plt and LDH values and at 24 and 48 hours for bilirubin. Trends for AST and Plt differed significantly between the recovery and progression groups in the first 48 hours. Patients who progressed had acute kidney injury and other severe maternal morbidity, including one case of maternal death. CONCLUSIONS: Women with HELLP syndrome without clear Plt and AST improvement in the first 48 hours and with acute kidney injury, neurological impairment, or respiratory distress syndrome are at risk of progressing to PTMS. They should be administered PPEX between 24 and 72 hours postpartum.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031523
003      
CZ-PrNML
005      
20160613093414.0
007      
ta
008      
151005s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.transci.2014.12.009 $2 doi
035    __
$a (PubMed)25571785
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Simetka, O $u Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava, Czech Republic; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Electronic address: ondrej.simetka@fno.cz.
245    10
$a Early identification of women with HELLP syndrome who need plasma exchange after delivery / $c O. Simetka, J. Klat, J. Gumulec, E. Dolezalkova, D. Salounova, M. Kacerovsky,
520    9_
$a OBJECTIVES: To compare the laboratory course of HELLP syndrome between patients who recover and those who progress to postpartum thrombotic microangiopathic syndrome (PTMS) and require postpartum plasma exchange (PPEX) and to describe maternal characteristics and morbidity in women with PTMS. METHODS: In this retrospective analysis, 81 patients recovered and 5 progressed. Values for aspartate aminotransferase (AST), lactate dehydrogenase (LDH), bilirubin, platelets (Plt), urea, and creatinine at 0, 8, 16, 24, 48, and 72 hours postpartum in both groups were analyzed and compared. We also described maternal characteristics and morbidity of patients who progressed to PTMS. RESULTS: Patient groups differed significantly at 72 hours postpartum for Plt and LDH values and at 24 and 48 hours for bilirubin. Trends for AST and Plt differed significantly between the recovery and progression groups in the first 48 hours. Patients who progressed had acute kidney injury and other severe maternal morbidity, including one case of maternal death. CONCLUSIONS: Women with HELLP syndrome without clear Plt and AST improvement in the first 48 hours and with acute kidney injury, neurological impairment, or respiratory distress syndrome are at risk of progressing to PTMS. They should be administered PPEX between 24 and 72 hours postpartum.
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    12
$a HELLP syndrom $x krev $x diagnóza $x terapie $7 D017359
650    _2
$a lidé $7 D006801
650    12
$a narození živého dítěte $7 D050498
650    12
$a výměna plazmy $7 D010951
650    _2
$a poporodní období $x krev $7 D049590
650    _2
$a těhotenství $7 D011247
650    12
$a poruchy v puerperiu $x krev $x diagnóza $x terapie $7 D011644
650    12
$a trombotické mikroangiopatie $x krev $x diagnóza $x terapie $7 D057049
650    _2
$a časové faktory $7 D013997
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Klát, Jaroslav $u Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava, Czech Republic; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. $7 osd2016913393
700    1_
$a Gumulec, J $u Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
700    1_
$a Dolezalkova, E $u Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava, Czech Republic.
700    1_
$a Salounova, D $u Department of Mathematical Methods in Economy, VSB-Technical University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Kacerovsky, M $u Department of Obstetrics and Gynecology, Charles University and University Hospital, Hradec Kralove, Czech Republic.
773    0_
$w MED00008583 $t Transfusion and apheresis science official journal of the World Apheresis Association official journal of the European Society for Haemapheresis $x 1473-0502 $g Roč. 52, č. 1 (2015), s. 54-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25571785 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20160613093544 $b ABA008
999    __
$a ok $b bmc $g 1092399 $s 914649
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 52 $c 1 $d 54-9 $e 20141218 $i 1473-0502 $m Transfusion and apheresis science $n Transfus Apher Sci $x MED00008583
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Možnosti archivace